Why Fulcrum Therapeutics Stock Is Back in Focus Fulcrum Therapeutics (FULC) is back on investors' radar after the company scrapped development of its lead sickle cell disease drug, pociredir, and ...
Fulcrum Therapeutics said today it is scrapping its lead pipeline program to develop pociredir as a treatment for sickle cell ...
― Decision follows FDA feedback regarding the implications of the secondary malignancies observed with Tazverik ® (tazemetostat) and the product’s subsequent global withdrawal on the benefit-risk ...
'This is intellectual property we have developed to provide actionable AI to customers,' says Fulcrum IT Partners President Kyle Lanzinger. 'We are productizing the AI-based vertical market domain ...
The rocker arm employs the use of a fulcrum or pivot to increase the cam lift by a given ratio. That increase in lift is the result of moving the pushrod pivot point closer to the fulcrum. That ...
New roadmap introduces intelligent, hands-free operations powered by Agentic AI, setting a bold new standard for productivity, safety, and compliance in critical infrastructure industries San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results